Serum microRNA profiles as diagnostic biomarkers for HBV‐positive hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Liver international (Print)

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/liv.13356PMID 28061012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulation of miR-192-5p protects from oxidative stress-induced acute liver injury.

  2016cited by this paper
• Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes

  2015cited by this paper
• Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells.

  2015cited by this paper
• Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing.

  2014cited by this paper
• A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus

  2014cited by this paper
• Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma

  2014cited by this paper
• Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment

  2014cited by this paper
• On‐treatment alpha‐fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir

  2014cited by this paper
• Tumor markers for hepatocellular carcinoma

  2013cited by this paper
• Circulating microRNAs as a Fingerprint for Liver Cirrhosis

  2013cited by this paper
• Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer.

  2013cited by this paper
• Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000–10

  2013cited by this paper
• Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.

  2013cited by this paper
• Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis

  2013cited by this paper
• Small RNA isolation and library construction for expression profiling of small RNAs from Neurospora and Fusarium using illumina high-throughput deep sequencing.

  2012cited by this paper
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

  2012cited by this paper
• The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011

  2012cited by this paper
• EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

  2012cited by this paper
• Circulating MicroRNAs: Molecular Microsensors in Gastrointestinal Cancer

  2012cited by this paper
• Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.

  2012cited by this paper
• Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.

  2012cited by this paper
• The potential of microRNAs in liver fibrosis.

  2012cited by this paper
• Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

  2011cited by this paper
• Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients

  2011cited by this paper
• Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.

  2011cited by this paper
• Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease

  2011cited by this paper
• Characterization of extracellular circulating microRNA

  2011cited by this paper
• Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis

  2011cited by this paper
• Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.

  2010cited by this paper
• Recurrence Patterns After Hepatectomy of Hepatocellular Carcinoma: Implication of Milan Criteria Utilization

  2009cited by this paper
• Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

  2008cited by this paper
• Serum MicroRNAs Are Promising Novel Biomarkers

  2008cited by this paper
• Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells.

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications.

  2008cited by this paper
• Design and endpoints of clinical trials in hepatocellular carcinoma.

  2008cited by this paper
• Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

  2008cited by this paper
• Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

  2007cited by this paper
• Management of hepatocellular carcinoma

  2005cited by this paper
• Randomized controlled trial of screening for hepatocellular carcinoma

  2004cited by this paper
• The functions of animal microRNAs

  2004cited by this paper
• Screening for hepatocellular carcinoma

  1998cited by this paper
• The significance of digital gene expression profiles.

  1997cited by this paper
• Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.

  1994cited by this paper
• Prospective study of α‐fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

  1994cited by this paper
• Management of hepatocellular carcinoma.

  1992cited by this paper
• Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?

  1989cited by this paper

• Diagnostic exosomal microRNAs and pathogenic regulatory networks in hepatocellular carcinoma revealed by exosomal RNA sequencing: A case–control study

  2026cites this paper
• Establishing a miRNA panel for hepatocellular carcinoma screening through a multicenter study

  2025cites this paper
• Circulating microRNA signatures for echinococcosis

  2025cites this paper
• Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population

  2023cites this paper
• Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy

  2023cites this paper
• Diagnosis of echinococcosis by detecting circulating cell-free DNA and miRNA

  2023cites this paper
• Circulating Micrornas: Diagnostic Value As Biomarkers In the Detection Of Non-Alcoholic Fatty Liver Diseases and Hepatocellular Carcinoma.

  2023cites this paper
• Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers

  2023cites this paper
• The Pro-Tumor Biological Function of IL-36α Plays an Important Role in the Tumor Microenvironment of HCC

  2023cites this paper
• Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology

  2022cites this paper
• circRanGAP1/miR-27b-3p/NRAS Axis may promote the progression of hepatocellular Carcinoma

  2022cites this paper
• Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma

  2022cites this paper
• microRNA-27b regulates hepatic lipase enzyme LIPC and reduces triglyceride degradation during hepatitis C virus infection

  2022cites this paper
• The Mechanisms of HBV-Induced Hepatocellular Carcinoma

  2021cites this paper
• Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis

  2021cites this paper
• Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma

  2021cites this paper
• The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B

  2021cites this paper
• Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside

  2021cites this paper
• A Physically Active Status Affects the Circulating Profile of Cancer-Associated miRNAs

  2021cites this paper
• Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma

  2021cites this paper
• Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis based on Asian data.

  2021cites this paper
• Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma

  2021cites this paper
• Can parasite-derived microRNAs differentiate active and inactive cystic echinococcosis patients?

  2021cites this paper
• Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosis

  2020cites this paper
• Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets

  2020cites this paper
• Blood exosomal miRNA profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers as differential diagnosis

  2020cites this paper
• Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening

  2020influential citation
• Parasite-derived microRNAs in plasma as novel promising biomarkers for the early detection of hydatid cyst infection and post-surgery follow-up.

  2020cites this paper
• miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers.

  2020cites this paper
• The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics

  2019cites this paper
• The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis

  2019cites this paper
• MicroRNAs as potential diagnostic and prognostic biomarkers in hepatocellular carcinoma.

  2019cites this paper
• Hepatocellular carcinoma: Mechanisms of progression and immunotherapy

  2019cites this paper
• Diagnostic Value of Circulating microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

  2019cites this paper
• Circulating microRNAs for the diagnosis of hepatocellular carcinoma.

  2019cites this paper
• miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.

  2019cites this paper
• Micro RNA‐4651 Serves as a Potential Biomarker for Prognosis When Selecting Hepatocellular Carcinoma Patients for Postoperative Adjuvant Transarterial Chemoembolization Therapy

  2018cites this paper
• Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis

  2018cites this paper
• Hepatitis B virus upregulates host microRNAs that target apoptosis‐regulatory genes in an in vitro cell model

  2018cites this paper
• Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma

  2018influential citation
• Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis

  2018cites this paper
• The Diagnostic and Prognostic Potential of MicroRNAs for Hepatocellular Carcinoma

  2017cites this paper
• RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines

  2017cites this paper
• Identification of an 88-microRNA signature in whole blood for diagnosis of hepatocellular carcinoma and other chronic liver diseases

  2017cites this paper
• Presence of Viral microRNA in Extracellular Environments

  2017influential citation
• miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1

  2017cites this paper
• Title: Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta- analysis based on Asian data Authors:

  year unknowncites this paper